FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Strides Pharma Science Potassium Chloride Extended-Release Tablets Recall

Potassium Chloride Extended-Release Tablets USP, 10mEq (750mg), 1000-count bottle, Rx…

Strides Pharma Science Limited

Risk level
Class III
Reported by FDA
Mar 25, 2020
Recall ID
D-1029-2020
Check your lot numberHow we source this data

Summary

Strides Pharma Science recalled Potassium Chloride Extended-Release Tablets starting Feb 17, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1029-2020 on Mar 25, 2020. Reason: Failed Tablet/Capsules Specifications: Oversized tablets were found in one lot of Potassium Chloride Tablets 750 mg. Status: Terminated.

Why it was recalled

Failed Tablet/Capsules Specifications: Oversized tablets were found in one lot of Potassium Chloride Tablets 750 mg.

Product description

Potassium Chloride Extended-Release Tablets USP, 10mEq (750mg), 1000-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-861-08

Lot numbers, UPCs & expiration codes

Lot #: 7238958A, 7238257A, Exp 7/31/2021; 7239404A, Exp 9/30/2021

Where it was sold

U.S.A. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1029-2020
Classification
Class III
Status
Terminated
Recall initiated
Feb 17, 2020
FDA report date
Mar 25, 2020
Quantity
2576 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Strides Pharma Science Limited

Original FDA data

Every field from FDA enforcement report D-1029-2020, exactly as published.

Show all FDA fields
City
Bangalore
Status
Terminated
Country
India
Event ID
84968
Address
Krs Gardens, No.36/7 Suragajakkanahalli
Address (line 2)
Indlawadi Cross, Anekal Taluk
Code information
Lot #: 7238958A, 7238257A, Exp 7/31/2021; 7239404A, Exp 9/30/2021
Report date
Mar 25, 2020
Product type
Drugs
Recall number
D-1029-2020
Classification
Class III
Recalling firm
Strides Pharma Science Limited
Product quantity
2576 bottles
Termination date
Feb 16, 2021
Reason for recall
Failed Tablet/Capsules Specifications: Oversized tablets were found in one lot of Potassium Chloride Tablets 750 mg.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Potassium Chloride Extended-Release Tablets USP, 10mEq (750mg), 1000-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-861-08
Distribution pattern
U.S.A. Nationwide
Recall initiation date
Feb 17, 2020
Initial firm notification
Letter
Center classification date
Mar 13, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1029-2020, published Mar 25, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls